Biotech · Private company
TerSera Therapeutics LLC
Track this companyFree. Adds TerSera Therapeutics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- anti-CD20 such as Rituximab or PaclitaxelPhase 2 · Oncology Patients Receiving ChemotherapyClinicalTrials.gov · fetched Nov 12, 2026
- Cetirizine HCl 10 mg/mLPhase 2 · Oncology Patients Receiving ChemotherapyClinicalTrials.gov · fetched Nov 12, 2026
- Diphenhydramine 50 mg/mLPhase 2 · Oncology Patients Receiving ChemotherapyClinicalTrials.gov · fetched Nov 12, 2026
- telotristat ethylPhase 2 · Biliary Tract Cancer (BTC)ClinicalTrials.gov · fetched Nov 12, 2026
- ZOLADEXPhase 1 · Advanced Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- XermeloCarcinoid SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast CancerPHASE1 · RECRUITING · started Oct 30, 2026ClinicalTrials.gov NCT07310420 · fetched Nov 12, 2026
- Intrathecal Ziconotide in Chemotherapy Induced Peripheral NeuropathyNOT_YET_RECRUITING · started May 2, 2026ClinicalTrials.gov NCT07499882 · fetched Nov 12, 2026
- Telotristat With Lutathera in Neuroendocrine TumorsPHASE2 · TERMINATED · started Sep 13, 2021ClinicalTrials.gov NCT04543955 · fetched Nov 12, 2026
- Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V DiphenhydraminePHASE2 · COMPLETED · started Mar 25, 2020ClinicalTrials.gov NCT04189588 · fetched Nov 12, 2026
- A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract CancerPHASE2 · TERMINATED · started Mar 13, 2019ClinicalTrials.gov NCT03790111 · fetched Nov 12, 2026
- Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELOCOMPLETED · started Jun 22, 2017ClinicalTrials.gov NCT03223428 · fetched Nov 12, 2026